Showing results (281-290 of 345) with videos related to
Sort By:
Pageof 35
Experimental Cell Research|September 6, 2002
Suppression of the transformed phenotype of breast cancer by tropomyosin-1Kalyankar Mahadev, Gira Raval, Shantaram Bharadwaj, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 22, 2016
Bromodomain and Extraterminal Protein Inhibitor JQ1 Suppresses Thyroid Tumor Growth in a Mouse ModelXuguang Zhu, Keisuke Enomoto, Li Zhao, et al.Journal of Clinical Oncology and Research|May 29, 2015
F10 Inhibits Growth of PC3 Xenografts and Enhances the Effects of Radiation TherapyWilliam H Gmeiner, Mark C Willingham, J Daniel Bourland, et al.Biochimica Et Biophysica Acta|April 15, 2008
Novel translocation responses of cytosolic phospholipase A2alpha fluorescent proteinsRhonda E Wooten, Mark C Willingham, Larry W Daniel, et al.Endocrinology|August 23, 2003
Modulation by steroid receptor coactivator-1 of target-tissue responsiveness in resistance to thyroid hormoneYuji Kamiya, Xiao-Yong Zhang, Hao Ying, et al.The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|January 1, 1989
Characterization of a monoclonal antibody, OVB1, which binds to a unique determinant in human ovarian carcinomas and myeloid cellsR H Kurrasch, A V Rutherford, M E Rick, et al.The Journal of Clinical Investigation|October 14, 2006
Aberrant accumulation of PTTG1 induced by a mutated thyroid hormone beta receptor inhibits mitotic progressionHao Ying, Fumihiko Furuya, Li Zhao, et al.Bioconjugate Chemistry|November 20, 2003
Diphtheria toxin-epidermal growth factor fusion protein and Pseudomonas exotoxin-interleukin 13 fusion protein exert synergistic toxicity against human glioblastoma multiforme cellsTie Fu Liu, Mark C Willingham, Stephen B Tatter, et al.The Journal of Clinical Investigation|September 1, 1985
Characterization of immunotoxins active against ovarian cancer cell linesR Pirker, D J FitzGerald, T C Hamilton, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 1, 1996
Enhancement of radiation dose to the nucleus by vesicular internalization of iodine-125-labeled A33 monoclonal antibodyF Daghighian, E Barendswaard, S Welt, et al.Pageof 35